TrialBMC pulmonary medicine2014

Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trial.

Lucas M A Goossens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.